본문 바로가기
카피라이터 바로가기
Greetings
Mission
Brief History
General Info
Major Activities
External Cooperation
Vision 2020
Location
Site Links
Introduction
Organization
B&D Cancer Therapeutics
Facilities
Equipment
Characteristics of Patient Care System
Organization
Medical Equipment
Internation Cancer Care Center
Introduction
Organization
National Cancer Control Programs
Cancer Facts and Figures of Korea
National Cancer Information Center
Symposium
Forum
Program
Visiting Fellow Program
Multimedia
Publications
Journals
News & Notice
Symbol Mark
Center list
the 51st Annual Meeting of Particle Therapy Co-Operative Group (PTCOG51)
The good, the bad and the truth on cancer
The 5th APOCP Regional Conference
The 4th ICCC
The 5th NCC International Symposium
Asia-Pacific Quit-Line Workshop
WHO Regional High-Level Meeting (March 17~18, 2011)
NCC signs MOU with NCI USA
Association and Haplotype Analysis of Prostate Stem Cell Antigen with Prostate Cancer Risk
Invited educational program on cancer diagnosis, treatment and management of cancer hospital (Kazakh...
International Workshop on Control of cancer as part of NCD
BIO KOREA 2010
SOCS5 and SOCS6 have similar expression patterns in normal and cancer tissues
Association of sociodemographic factors, smoking-related beliefs, and smoking restrictions with inte
Comparison of surgical performance and short-term clinical outcomes between laparoscopic and robotic
Programmed cell death 6 (PDCD6) inhibits angiogenesis through PI3K/mTOR/p70S6K pathway by interactin
Role of Adjuvant Chemoradiotherapy for Resected Extrahepatic Biliary Tract Cancer.
Cancer cells promote survival through depletion of the von Hippel Lindau tumor suppressor by protein
Locoregional recurrence of breast cancer in patients treated with breast conservation surgery and ra
Effect of Obesity on Survival of Women With Epithelial Ovarian Cancer: A Systematic Review and Meta-
Galectin-3 germline variant at position 191 enhances nuclear accumulation and activation of β-cateni
Outcomes of Positron Emission Tomography-Staged Clinical N3 Breast Cancer Treated with Neoadjuvant C